Zurück

Wählen Sie Ihre Region

Corporate

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Unsere
Transplantationen

Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

Obraz
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
1501 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy Poland 2
1502 Bone Marrow Allogeneic Severe Congenital Neutropenia Hematology 2024 Standard Therapy Poland 1
1503 Bone Marrow Allogeneic Shwachman-Diamond Syndrome Hematology 2024 Standard Therapy Poland 10
1504 Bone Marrow Allogeneic Sickle Cell Disease Hematology 2024 Standard Therapy Poland 9
1505 Bone Marrow Allogeneic Biphenotypic Acute Leukemia Hematology 2024 Standard Therapy Ukraine 10
1506 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
1507 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy United Kingdom 12
1508 Bone Marrow Allogeneic hemophagocytic lymphohistiocytosis Hematology 2024 Standard Therapy Sweden 4 months
1509 Bone Marrow Allogeneic Severe combined immunodeficiency Hematology 2024 Standard Therapy Germany 1
1510 Bone Marrow Allogeneic Beta-Thalassemia Major Hematology 2024 Standard Therapy India 11
1511 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Austria 4
1512 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Norway 33
1513 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Spain 16
1514 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Switzerland 5
1515 Bone Marrow Allogeneic T- Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Ireland 6
1516 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 12
1517 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2024 Standard Therapy USA 4 months
1518 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Belgium 50
1519 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy France 31
1520 Bone Marrow Allogeneic Chronic myelomonocytic leukemia Hematology 2024 Standard Therapy Italy 64
1521 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy France 10
1522 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 12
1523 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy USA 4
1524 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Canada 8
1525 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy Poland 17
1526 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 8
1527 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 67
1528 Bone Marrow Allogeneic Hodgkins Lymphoma Hematology 2024 Standard Therapy United Kingdom 36
1529 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 72
1530 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 9
1531 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2024 Standard Therapy USA 3
1532 Apheresis Allogeneic A- Thalassemia Hematology 2024 Standard Therapy Poland 11
1533 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 13
1534 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 21
1535 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 22
1536 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 38
1537 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 41
1538 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1539 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1540 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 48
1541 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 50
1542 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 50
1543 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 55
1544 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 59
1545 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 60
1546 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 63
1547 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 44
1548 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 59
1549 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 51
1550 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 34
1551 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 1
1552 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 10
1553 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 20
1554 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 25
1555 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 26
1556 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 28
1557 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 34
1558 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 35
1559 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 37
1560 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 38
1561 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 38
1562 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 40
1563 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 41
1564 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 43
1565 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 51
1566 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 51
1567 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 51
1568 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 59
1569 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 59
1570 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 60
1571 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 60
1572 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 60
1573 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 61
1574 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 61
1575 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 62
1576 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 62
1577 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 64
1578 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 65
1579 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 66
1580 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 67
1581 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 67
1582 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 68
1583 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1584 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1585 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1586 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1587 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 69
1588 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1589 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 70
1590 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 72
1591 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 73
1592 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 77
1593 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 59
1594 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 66
1595 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
1596 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 54
1597 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 29
1598 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 64
1599 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 27
1600 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 60